title: [Clinical results after cataract surgery in patients with Behçet's disease].
abstract: BACKGROUND
  Behçet's disease is a systemic vasculitis disorder of unknown aetiology. Ocular involvement, especially with vasculitis, is detected in up to 80 % of the cases. Anterior segment involvement such as cataract is also seen in the follow-up of patients who are then treated surgically. In this study, we aimed to analyze the outcomes of cataract surgery in patients with Behçet's disease retrospectively.
  
  
  METHODS
  The records of 9 patients (12 eyes) with Behçet's disease who underwent phacoemulsification with IOL implantation in 11 eyes and extracapsular cataract extraction (ECCE) with IOL implantation in one eye between June 2001 and September 2009 were evaluated retrospectively. The visual outcome and complications were analysed.
  
  
  RESULTS
  The mean follow-up was 33.8 months (range 3 to 88 months). The mean preoperative LogMAR BCVA was 1.15 ± 0.53 (95 % CI: 0.81 - 1.49) and increased to 0.36 ± 0.32 (95 % CI: 0.15 - 0.56) at last medical visit (p < 0.001). The most frequent postoperative complication was posterior capsular opacification, which developed in 2 eyes (17 %). Other complications were mild fibrinous reaction in 1 eye (8 %).
  
  
  CONCLUSIONS
  The outcomes of cataract surgery in patients with Behçet's disease were satisfactory. The great majority of the patients regained and retained a good visual outcome and had fewer postoperative complications.
authors.affiliation: Department für Augenheilkunde, Universitätsklinikum Gaziantep.
authors.forename: O
authors.initials: O
authors.lastname: Saygili
authors.forename: P
authors.initials: P
authors.lastname: Szurman
authors.forename: S
authors.initials: S
authors.lastname: Gieselmann
authors.forename: C
authors.initials: C
authors.lastname: Deuter
authors.forename: M S
authors.initials: MS
authors.lastname: Spitzer
authors.forename: S
authors.initials: S
authors.lastname: Thaler
authors.forename: K U
authors.initials: KU
authors.lastname: Bartz-Schmidt
authors.forename: E
authors.initials: E
authors.lastname: Yoeruek
mesh_terms: D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D001379:Azathioprine / Q000008:administration & dosage; D001528:Behcet Syndrome / Q000601:surgery*; D002387:Cataract Extraction / Q000379:methods; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D007910:Lenses, Intraocular; D008297:Male; D008875:Middle Aged; D019990:Perioperative Care; D011183:Postoperative Complications / Q000209:etiology; D011239:Prednisolone / Q000008:administration & dosage; D011994:Recombinant Proteins / Q000008:administration & dosage; D012189:Retrospective Studies; D055815:Young Adult
chemical_list: D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011239:Prednisolone; D001379:Azathioprine